Ataxion's Acquisition

Ataxion was acquired by Luc Therapeutics on March 07, 2017.

Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic diseases in partnership with Biogen. Ataxion is leveraging the expe…

Articles about Ataxion's Acquisition: